| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 6 2928-2937, Copyright © 1995 by American Association of Immunologists
ARTICLES |
A Noble, PA Macary and DM Kemeny
Department of Allergy and Allied Respiratory Disorders, United Medical School, Guy's Hospital, London, UK.
In this study, we have investigated the effects of IL-4 and IFN-gamma on the growth and differentiation of CD8+ T cells in vitro. Rat splenic CD8+ T cells expressed higher levels of IL-4, IL-5, IL-10, and IFN- gamma mRNA, as measured by reverse-transcription PCR, than CD4+ T cells from the same source, whereas CD4+ T cells expressed more IL-2 and IL-6 mRNA. CD8+ T cells were cultured for 6 days with PMA, ionomycin, and IL- 2, and their ability to proliferate, to express mRNA for IL-2, IL-4, IL- 5, IL-6, IL-10, and IFN-gamma, and to secrete IFN-gamma and IL-2 was determined. IL-4 could act as a growth factor for CD8+ T cells during primary stimulation, but inhibited proliferation of the restimulated 6- day-cultured CD8+ T cells. The highest levels of mRNA for IL-2 and IL-6 were detected in control cultures in which little mRNA for IL-4, IL-5, or IL-10 was detected. Addition of IL-4 to the primary cultures reduced the capacity of the restimulated cells to express mRNA for IL-2, and for IL-6, but enhanced expression of mRNA for IL-4 and IL-5. Addition of IFN-gamma to the cultures, alone or in conjunction with IL-4, or addition of IFN-gamma-specific neutralizing Ab, had little effect. However, in conjunction with IL-4, anti-IFN-gamma enhanced expression of mRNA for IFN-gamma, and for IL-10. These results indicate that IL-4 and IFN-gamma regulate the differentiation of CD8+ T cells and the growth of cytotoxic and other types of CD8+ T cells, and suggest pathways through which CD8+ T cells may interact with other immune cells.
This article has been cited by other articles:
|
|
 |
|
  N. Nagata, N. Iwata, H. Hasegawa, S. Fukushi, A. Harashima, Y. Sato, M. Saijo, F. Taguchi, S. Morikawa, and T. Sata Mouse-Passaged Severe Acute Respiratory Syndrome-Associated Coronavirus Leads to Lethal Pulmonary Edema and Diffuse Alveolar Damage in Adult but Not Young Mice Am. J. Pathol., June 1, 2008; 172(6): 1625 - 1637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Xystrakis, P. Cavailles, A. S. Dejean, B. Cautain, C. Colacios, D. Lagrange, M.-J. van de Gaar, I. Bernard, D. Gonzalez-Dunia, J. Damoiseaux, et al. Functional and Genetic Analysis of Two CD8 T Cell Subsets Defined by the Level of CD45RC Expression in the Rat J. Immunol., September 1, 2004; 173(5): 3140 - 3147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Cooper, A. Mikhail, M. W. Lethbridge, D. M. Kemeny, and I. C. Macdougall Increased Expression of Erythropoiesis Inhibiting Cytokines (IFN-{gamma}, TNF-{alpha}, IL-10, and IL-13) by T Cells in Patients Exhibiting a Poor Response to Erythropoietin Therapy J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1776 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Antonini, J. R. Roberts, R. W. Clarke, H.-M. Yang, M. W. Barger, J. Y. C. Ma, and D. N. Weissman Effect of Age on Respiratory Defense Mechanisms : Pulmonary Bacterial Clearance in Fischer 344 Rats After Intratracheal Instillation of Listeria monocytogenes Chest, July 1, 2001; 120(1): 240 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Finch, P. E. Fields, and P. D. Greenberg A Transcriptional Block in the IL-2 Promoter at the -150 AP-1 Site in Effector CD8+ T Cells J. Immunol., June 1, 2001; 166(11): 6530 - 6536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Abe, T. Peng, J. Sailors, R. Bucala, and C. N. Metz Regulation of the CTL Response by Macrophage Migration Inhibitory Factor J. Immunol., January 15, 2001; 166(2): 747 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-J. Huang, P. A. MacAry, P. Eynott, A. Moussavi, K. C. Daniel, P. W. Askenase, D. M. Kemeny, and K. F. Chung Allergen-Specific Th1 Cells Counteract Efferent Th2 Cell-Dependent Bronchial Hyperresponsiveness and Eosinophilic Inflammation Partly Via IFN-{{gamma}} J. Immunol., January 1, 2001; 166(1): 207 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-I. Sin, J. Kim, C. Patchuk, and D. B. Weiner Interleukin 7 Can Enhance Antigen-Specific Cytotoxic-T-Lymphocyte and/or Th2-Type Immune Responses In Vivo Clin. Vaccine Immunol., September 1, 2000; 7(5): 751 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Diamond and R. G. Gill An Essential Contribution by IFN-{gamma} to CD8+ T Cell-Mediated Rejection of Pancreatic Islet Allografts J. Immunol., July 1, 2000; 165(1): 247 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Noble, J. P. Truman, B. Vyas, M. Vukmanovic-Stejic, W. J. Hirst, and D. Michael Kemeny The Balance of Protein Kinase C and Calcium Signaling Directs T Cell Subset Development J. Immunol., February 15, 2000; 164(4): 1807 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Vukmanovic-Stejic, B. Vyas, P. Gorak-Stolinska, A. Noble, and D. M. Kemeny Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes Blood, January 1, 2000; 95(1): 231 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Furukawa, G. Becker, J. L. Stinn, K. Shimizu, P. Libby, and R. N. Mitchell Interleukin-10 (IL-10) Augments Allograft Arterial Disease : Paradoxical Effects of IL-10 in Vivo Am. J. Pathol., December 1, 1999; 155(6): 1929 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. KEMENY, B. VYAS, M. VUKMANOVIC-STEJIC, M. J. THOMAS, A. NOBLE, L.-C. LOH, and B. J. O'CONNOR CD8+ T Cell Subsets and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S33 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Smith, A. S. Malin, Pauline T., Lukey, S. E. Atkinson, J. Content, K. Huygen, and H. M. Dockrell Characterization of Human Mycobacterium bovis Bacille Calmette-Guerin-Reactive CD8+ T Cells Infect. Immun., October 1, 1999; 67(10): 5223 - 5230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. M. C. Damoiseaux, B. Cautain, I. Bernard, M. Mas, P. J. C. van Breda Vriesman, P. Druet, G. Fournie, and A. Saoudi A Dominant Role for the Thymus and MHC Genes in Determining the Peripheral CD4/CD8 T Cell Ratio in the Rat J. Immunol., September 15, 1999; 163(6): 2983 - 2989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Dobrzanski, J. B. Reome, and R. W. Dutton Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T Cell Subpopulations in Established Pulmonary Metastases J. Immunol., June 1, 1999; 162(11): 6671 - 6680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Liebana, R. M. Girvin, M. Welsh, S. D. Neill, and J. M. Pollock Generation of CD8+ T-Cell Responses to Mycobacterium bovis and Mycobacterial Antigen in Experimental Bovine Tuberculosis Infect. Immun., March 1, 1999; 67(3): 1034 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Villacres and C. C. Bergmann Enhanced Cytotoxic T Cell Activity in IL-4-Deficient Mice J. Immunol., March 1, 1999; 162(5): 2663 - 2670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Farrar, K. H. Katz, J. Windsor, G. Thrush, R. H. Scheuermann, J. W. Uhr, and N. E. Street Cancer Dormancy. VII. A Regulatory Role for CD8+ T Cells and IFN-{gamma} in Establishing and Maintaining the Tumor-Dormant State J. Immunol., March 1, 1999; 162(5): 2842 - 2849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Matesic, A. Valujskikh, E. Pearlman, A. W. Higgins, A. C. Gilliam, and P. S. Heeger Type 2 Immune Deviation Has Differential Effects on Alloreactive CD4+ and CD8+ T Cells J. Immunol., November 15, 1998; 161(10): 5236 - 5244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Schlienger, K. Uyemura, D. Jullien, P. A. Sieling, T. H. Rea, P. S. Linsley3, and R. L. Modlin B7-1, But Not CD28, Is Crucial for the Maintenance of the CD4+ T Cell Responses in Human Leprosy J. Immunol., September 1, 1998; 161(5): 2407 - 2413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cerwenka, L. L. Carter, J. B. Reome, S. L. Swain, and R. W. Dutton In Vivo Persistence of CD8 Polarized T Cell Subsets Producing Type 1 or Type 2 Cytokines J. Immunol., July 1, 1998; 161(1): 97 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D W KIELY The Th1-Th2 model---what relevance to inflammatory arthritis? Ann Rheum Dis, June 1, 1998; 57(6): 328 - 330. [Full Text]
|
|
|
|
 |
|
 M. Kemeny and M. Peakman Recent advances: Immunology BMJ, February 14, 1998; 316(7131): 600 - 603. [Full Text]
|
|
|
|
|
|
P. A. MacAry, B. J. Holmes, and D. M. Kemeny Ovalbumin-Specific, MHC Class I-Restricted, {alpha}{beta}-Positive, Tc1 and Tc0 CD8+ T Cell Clones Mediate the In Vivo Inhibition of Rat IgE J. Immunol., January 15, 1998; 160(2): 580 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Agostini, L. Trentin, R. Sancetta, M. Facco, C. Tassinari, A. Cerutti, M. Bortolin, A. Milani, M. Siviero, R. Zambello, et al. Interleukin-15 Triggers Activation and Growth of the CD8 T-Cell Pool in Extravascular Tissues of Patients With Acquired Immunodeficiency Syndrome Blood, August 1, 1997; 90(3): 1115 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zambello, M. Facco, L. Trentin, R. Sancetta, C. Tassinari, A. Perin, A. Milani, G. Pizzolo, F. Rodeghiero, C. Agostini, et al. Interleukin-15 Triggers the Proliferation and Cytotoxicity of Granular Lymphocytes in Patients With Lymphoproliferative Disease of Granular Lymphocytes Blood, January 1, 1997; 89(1): 201 - 211. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
